IGC Pharma (IGC) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $41000.0.
- Pharma's Receivables - Net fell 681.82% to $41000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41000.0, marking a year-over-year decrease of 681.82%. This contributed to the annual value of $34000.0 for FY2025, which is 1282.05% down from last year.
- As of Q3 2025, Pharma's Receivables - Net stood at $41000.0, which was down 681.82% from $87000.0 recorded in Q2 2025.
- In the past 5 years, Pharma's Receivables - Net ranged from a high of $251000.0 in Q4 2022 and a low of $28000.0 during Q2 2024
- Over the past 5 years, Pharma's median Receivables - Net value was $125000.0 (recorded in 2022), while the average stood at $117578.9.
- Per our database at Business Quant, Pharma's Receivables - Net tumbled by 8755.56% in 2024 and then surged by 21071.43% in 2025.
- Pharma's Receivables - Net (Quarter) stood at $164000.0 in 2021, then soared by 53.05% to $251000.0 in 2022, then tumbled by 63.35% to $92000.0 in 2023, then plummeted by 46.74% to $49000.0 in 2024, then decreased by 16.33% to $41000.0 in 2025.
- Its Receivables - Net stands at $41000.0 for Q3 2025, versus $87000.0 for Q2 2025 and $34000.0 for Q1 2025.